Safety and Efficacy of Novel Oral Anticoagulants in the Setting of Atrial Fibrillation Ablation: Is It Time to Celebrate the “Funeral” of Warfarin?

Journal of Interventional Cardiac Electrophysiology - Netherlands
doi 10.1007/s10840-014-9944-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Cardiovascular and Hematological Disorders - Drug Targets
Molecular MedicinePharmacologyCardiologyHematologyCardiovascular MedicineMedicine
2015English

Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis of the Literature

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients With Renal Impairment

Pharmacy
2020English

Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Comparison of Effectiveness and Safety Between Uninterrupted Direct Oral Anticoagulants With and Without Switching to Dabigatran in Atrial Fibrillation Ablation

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2020English

Activated Clotting Time on the Day of Atrial Fibrillation Ablation for Minimally Interrupted and Uninterrupted Direct Oral Anticoagulation Therapy: Sequential Changes, Differences Among Direct Oral Anticoagulants, and Ablation Safety Outcomes

Journal of Cardiovascular Electrophysiology
Cardiovascular MedicinePhysiologyCardiology
2019English

Prevention of Cardiovascular Outcomes in Diabetic Patients With Atrial Fibrillation: Direct Oral Anticoagulants or Warfarin?

Clinical pharmacology and therapy
2019English

The Safety and Efficacy of Hybrid Ablation for the Treatment of Atrial Fibrillation: A Meta-Analysis

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy